Neovacs’ Board consists of six experienced directors, from varied professional backgrounds. Two Board Members are Independent Directors.
Ex-Chairman of Pierre Fabre Group and Guerbet S.A
Ex-Former Chairman and CEO of Aventis Pasteur and former chairman of the French pharmaceutical industry association LEEM
Daniel Zagury, MD, PhD
Founder of Neovacs
Arlene Morris (independent Director)
Director of MUSC Foundation for Research and Development and BIO (U.S.A)
25 years of management experience from Johnson & Johnson’s, Ortho-McNeil Pharmaceutical, Scios, Inc.,
Corixa Corporation and Clearview Projects, Inc.
Chief Executive Officer of Willow Advisors, LLC since 2015
She served as Director of Palatin Technologies Inc. and as a Director of Biodel Inc. since 2015
Ex-Chief Executive Officer and President of Syndax Pharmaceuticals, Inc. from 2013 to 2015
Ex-Director of Medicinova Inc. from May 11, 2006 to June 14, 2013
Patrick Valroff (independent Director)
Graduate from the IEP Paris and ENA
Ex-Chief Executive Officer at Crédit Agricole Corporate and Investment Bank S.A. and Executive Board member at Credit Agricole SA
He served as Head Clerk in the budget department of the French government
Jacques Banchereau, Ph.D.
President of Neovacs’ Scientific Advisory Board
Jackson Laboratory for Genomic Medicine, Farmington, Conn. (U.S.A)
3-5, Impasse Reille
Tel. : 33 (0)1 53 10 93 00
Fax : 33 (0)1 53 10 93 03
POURQUOI INVESTIR ?VOIR L’ESPACE INVESTISSEURS